475 related articles for article (PubMed ID: 7688054)
1. Serum prostate-specific antigen in a community-based population of healthy men. Establishment of age-specific reference ranges.
Oesterling JE; Jacobsen SJ; Chute CG; Guess HA; Girman CJ; Panser LA; Lieber MM
JAMA; 1993 Aug; 270(7):860-4. PubMed ID: 7688054
[TBL] [Abstract][Full Text] [Related]
2. Early diagnosis of prostate cancer in the Western Cape.
Heyns CF; Naudé AM; Visser AJ; Marais DC; Stopforth HB; Nyarko JK; Stellmacher GA
S Afr Med J; 2001 Aug; 91(8):679-84. PubMed ID: 11584784
[TBL] [Abstract][Full Text] [Related]
3. Ethnic differences in the age-related distribution of serum prostate-specific antigen values: a study in a healthy Korean male population.
Lee SE; Kwak C; Park MS; Lee CH; Kang W; Oh SJ
Urology; 2000 Dec; 56(6):1007-10. PubMed ID: 11113748
[TBL] [Abstract][Full Text] [Related]
4. Detection of prostatic carcinoma: the role of TRUS, TRUS guided biopsy, digital rectal examination, PSA and PSA density.
Men S; Cakar B; Conkbayir I; Hekimoglu B
J Exp Clin Cancer Res; 2001 Dec; 20(4):473-80. PubMed ID: 11876539
[TBL] [Abstract][Full Text] [Related]
5. Percent free prostate specific antigen in the total prostate specific antigen 2 to 4 ng./ml. range does not substantially increase the number of biopsies needed to detect clinically significant prostate cancer compared to the 4 to 10 ng./ml. range.
Haese A; Dworschack RT; Partin AW
J Urol; 2002 Aug; 168(2):504-8. PubMed ID: 12131298
[TBL] [Abstract][Full Text] [Related]
6. Preoperative serum prostate specific antigen levels between 2 and 22 ng./ml. correlate poorly with post-radical prostatectomy cancer morphology: prostate specific antigen cure rates appear constant between 2 and 9 ng./ml.
Stamey TA; Johnstone IM; McNeal JE; Lu AY; Yemoto CM
J Urol; 2002 Jan; 167(1):103-11. PubMed ID: 11743285
[TBL] [Abstract][Full Text] [Related]
7. [Additional aids in detection of prostate carcinomas? PSA-prostatic volume quotient, PSA-doubling time, age-dependent PSA reference values and PSA in urine].
Pannek J; Brands FH
Urologe A; 2000 Jul; 39(4):324-9. PubMed ID: 10957773
[TBL] [Abstract][Full Text] [Related]
8. Calculated fast-growing benign prostatic hyperplasia--a risk factor for developing clinical prostate cancer.
Hammarsten J; Högstedt B
Scand J Urol Nephrol; 2002; 36(5):330-8. PubMed ID: 12487736
[TBL] [Abstract][Full Text] [Related]
9. Distribution of serum prostate-specific antigen in healthy Korean men: influence of ethnicity.
Ku JH; Ahn JO; Lee CH; Lee NK; Park YH; Byun SS; Kwak C; Lee SE
Urology; 2002 Sep; 60(3):475-9. PubMed ID: 12350489
[TBL] [Abstract][Full Text] [Related]
10. Relationship between age, prostate volume, prostate-specific antigen, symptom score and uroflowmetry in men with lower urinary tract symptoms.
Vesely S; Knutson T; Damber JE; Dicuio M; Dahlstrand C
Scand J Urol Nephrol; 2003; 37(4):322-8. PubMed ID: 12944191
[TBL] [Abstract][Full Text] [Related]
11. Relationship between Prostatic Specific Antigen (PSA) and volume of the prostate in the Benign Prostatic Hyperplasia in the elderly.
Bo M; Ventura M; Marinello R; Capello S; Casetta G; Fabris F
Crit Rev Oncol Hematol; 2003 Sep; 47(3):207-11. PubMed ID: 12962896
[TBL] [Abstract][Full Text] [Related]
12. Age-specific distribution of serum prostate-specific antigen in a community-based study of African-American men.
Cooney KA; Strawderman MS; Wojno KJ; Doerr KM; Taylor A; Alcser KH; Heeringa SG; Taylor JM; Wei JT; Montie JE; Schottenfeld D
Urology; 2001 Jan; 57(1):91-6. PubMed ID: 11164150
[TBL] [Abstract][Full Text] [Related]
13. Discrimination of benign from malignant prostatic disease by selective measurements of single chain, intact free prostate specific antigen.
Steuber T; Nurmikko P; Haese A; Pettersson K; Graefen M; Hammerer P; Huland H; Lilja H
J Urol; 2002 Nov; 168(5):1917-22. PubMed ID: 12394676
[TBL] [Abstract][Full Text] [Related]
14. Variation of serum prostate-specific antigen levels: an evaluation of year-to-year fluctuations.
Eastham JA; Riedel E; Scardino PT; Shike M; Fleisher M; Schatzkin A; Lanza E; Latkany L; Begg CB;
JAMA; 2003 May; 289(20):2695-700. PubMed ID: 12771116
[TBL] [Abstract][Full Text] [Related]
15. Usefulness of age-specific reference range of prostate-specific antigen for Japanese men older than 60 years in mass screening for prostate cancer.
Ito K; Yamamoto T; Kubota Y; Suzuki K; Fukabori Y; Kurokawa K; Yamanaka H
Urology; 2000 Aug; 56(2):278-82. PubMed ID: 10925094
[TBL] [Abstract][Full Text] [Related]
16. Age-related reference ranges for complexed prostate-specific antigen and complexed/total prostate-specific antigen ratio: results from East Texas Medical Center Cancer Institute screening campaign.
Cheli CD; Levine RL; Cambetas DR; Kolker JD; Roberts SB
Urology; 2002 Oct; 60(4 Suppl 1):53-9. PubMed ID: 12384164
[TBL] [Abstract][Full Text] [Related]
17. Prostate-specific antigen as an estimator of prostate volume in the management of patients with symptomatic benign prostatic hyperplasia.
Mochtar CA; Kiemeney LA; van Riemsdijk MM; Barnett GS; Laguna MP; Debruyne FM; de la Rosette JJ
Eur Urol; 2003 Dec; 44(6):695-700. PubMed ID: 14644122
[TBL] [Abstract][Full Text] [Related]
18. Natural history of PSA increase with and without prostate cancer.
Ito K; Yamamoto T; Ohi M; Takechi H; Kurokawa K; Suzuki K; Yamanaka H
Urology; 2003 Jul; 62(1):64-9. PubMed ID: 12837424
[TBL] [Abstract][Full Text] [Related]
19. Prostatic calculi do not influence the level of serum prostate specific antigen in men without clinically detectable prostate cancer or prostatitis.
Lee SE; Ku JH; Park HK; Jeong CK; Kim SH
J Urol; 2003 Sep; 170(3):745-8. PubMed ID: 12913688
[TBL] [Abstract][Full Text] [Related]
20. Determination of serum prostate-specific antigen-alpha1-antichymotrypsin complex for diagnosis of prostate cancer in Japanese cases.
Kuriyama M; Abrahamsson PA; Imai K; Akimoto S; Deguchi N; Shichiri Y; Sugiyama Y; Niwa T; Inoue T
Scand J Urol Nephrol; 2001 Feb; 35(1):5-10. PubMed ID: 11291689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
